We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The revolution in Chat GPT and other AI applications has seen an explosion in investment in recent years.
Quantum technologies are attracting major government funding, corporate funding and Wall Street enthusiasm.
Global demand for rare earths stocks is increasing, offering exposure to a strategically vital commodity.
Eli Lilly (LLY), the Indianapolis-based drugmaker, recently made news by becoming the first pharmaceutical company to top $1 trillion in market value, thanks in part to its breakout weight-loss drugs, Mounjaro and Zepbound. Are other pharma stocks worth a look?
Are Pharmaceutical Stocks a Good Investment?
Pharmaceutical firms have long been viewed as a blend of defensive income plays and growth opportunities. As demand for medicines, vaccines, and chronic-disease treatments remains steady regardless of economic cycles, pharma companies often deliver stable earnings. That stability — combined with generous dividends many pharma companies pay — makes them especially attractive when the broader market is choppy or inflation is high.
Additionally, the global pharmaceutical industry continues to grow: Analysts expect the sector to expand over the coming years, aided by rising demand for treatments for chronic illnesses, oncology, vaccines and demographic factors such as aging populations.
However, pharmaceutical investing isn’t risk-free. Outcomes often depend on R&D success, regulatory approvals, patent expirations, and competitive pressures. That’s why smart investors often balance stable dividend-payers with growth-oriented firms or diversify across multiple names.
Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.
Med
Market Cap2.5
Last EPS Surprise50
Current Price123
Our Take:
It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using Lorem Ipsum is that it has a more-or-less normal distribution of letters, as opposed to using 'Content here, content here', making it look like readable English. Many desktop publishing packages and web page editors now use Lorem Ipsum as their default model text, and a search for 'lorem ipsum' will uncover many web sites still in their infancy. Various versions have evolved over the years, sometimes by accident, sometimes on purpose (injected humour and the like).
Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.
Med
Best Stocks to Buy Now: How to Use This List
It’s important to understand what this list is, and what it isn’t.
For decades, the Zacks Rank has been a proven system that has helped investors identify stocks most likely to outperform. Instead of relying on hunches or hype, it’s grounded in earnings estimate revisions — a factor strongly correlated with stock price movement. When combined with additional fundamental metrics, the approach becomes even more powerful.
Still, it’s important to understand these basics:
While the list offers exposure across several industries, it is not a fully diversified portfolio. You should think of it as a starting point, not a complete investing strategy.
Even though these stocks are backed by a proven system, nothing protects you from short-term downside. Depending on market conditions, most — or even all — could decline in the near term.
The Zacks Rank works because it captures trends in earnings momentum. That power plays out over weeks and months, not days. Investors with patience and discipline are more likely to benefit.
Before buying any single stock, check how it aligns with your goals, risk tolerance, and broader portfolio.
Methodology
The Zacks Rank is a proprietary stock-rating model that uses trends in earnings estimate revisions and earnings-per-share (EPS) surprises to classify stocks into five groups: #1 (Strong Buy), #2 (Buy), #3 (Hold), #4 (Sell) and #5 (Strong Sell). The Zacks Rank is calculated through four primary factors related to earnings estimates: analysts' consensus on earnings estimate revisions, the magnitude of revision change, the upside potential and estimate surprise (or the degree in which earnings per share deviated from the previous quarter).
Zacks builds the data from 3,000 analysts at over 150 different brokerage firms. The average yearly gain for Zacks Rank #1 (Strong Buy) stocks is +23.62% per year from January, 1988, through June 2, 2025.
For this list, only companies in the top 50% of industries that have average daily trading volumes of 100,000 shares or more were considered. Stocks with a share value of $5 or less were excluded. These companies earned Zacks Rank #1 (Strong Buy) between Nov. 24 and Dec. 6, 2025. All information is current as of market open, Dec.8, 2025.
Common Questions of New Investors
Where to Buy Stocks
To invest in stocks, you must open a brokerage account, fund the account and purchase stocks through your selected brokerage. Investors may also purchase stocks through a financial advisor or an automated robo advisor. Some publicly traded companies also offer a direct stock purchase plan, where you can purchase shares directly from the company.
Alternative Ways to Invest in Stocks
You can also invest in stock funds, such as mutual funds, index funds and exchange-traded funds, where the fund managers select the pool of stocks that follow an investing strategy. These funds may broadly cover an entire index, such as the S&P 500, or specific types of stocks, such as industries like technology and energy companies, company size such as small cap companies, or location like international companies.
How to Start Investing in Stocks Today
It’s easy to start investing by opening an online brokerage account. Opening a standard brokerage account takes about 20 minutes and you’ll need to have some personal information ready, such as your social security number and your bank details to fund your account.
You’ll need to decide whether to open a taxable account (most common), a tax-deferred retirement account such as a traditional IRA or a tax-free retirement account such as a Roth IRA, which is funded with after-tax dollars, but qualified withdrawals are tax-free. A margin account allows for borrowing to purchase stocks and is best for experienced traders.
Set goals before you begin investing – determine how much you can afford to invest and your tolerance for risk.
What to Look for When You Buy Stocks?
The goal in all equities investment is to buy low and sell high, growing your wealth over time. Researching the companies to invest in is key – what kind of product or service do they offer? How do they compare with competitors? How fast are they growing? Does the stock pay regular dividends to shareholders? Does the stock help diversify your portfolio by giving you exposure to a market segment you currently don’t hold?
Understanding fundamental analysis can help determine whether the stock has the potential for growth at its current purchase price. Factors that can help determine that include earnings per share (EPS), price-to-earnings ratio and PE growth. Technical analysis is used looking at statistical patterns to potentially predict future price moves. Some investors may look for a growth and income strategy, looking for stocks with solid revenues that pay good dividends, or a value strategy, looking if a current stock price is below what their revenue, EPS and other factors suggest.
Analysts also often look for the momentum of a stock by looking at moving averages of a stock's closing price over a 50-day, 100-day or 12-month trailing time period to determine signals whether to buy or sell a stock.
View the Zacks #1 Rank List
